As of Jun 02
| -0.08 / -3.10%|
The 3 analysts offering 12-month price forecasts for Burning Rock Biotech Ltd have a median target of 3.84, with a high estimate of 8.65 and a low estimate of 3.74. The median estimate represents a +53.78% increase from the last price of 2.50.
The current consensus among 3 polled investment analysts is to Buy stock in Burning Rock Biotech Ltd. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.